Le Lézard
Classified in: Health
Subject: MAT

How Mary Jane's CBD Dispensary is Revolutionizing Retail


From its rapid nationwide growth and wellness focus to its loyal clientele base and renowned customer service, business is booming.

SAN ANTONIO, Aug. 21, 2023 /PRNewswire-PRWeb/ -- Mary Jane's CBD Dispensary is excited to announce the opening of five new locations in Texas, North Carolina, and Colorado in 2023, bringing the well-known retailer's total number of stores to more than 30 locations across eight different states.

What started as a journey to reinvent two struggling smoke shops back in 2018 has now become a testament to the power of strategic rebranding, innovation, customer satisfaction, and adaptability. As a result, the company has experienced exponential growth, establishing headquarters in San Antonio, Texas, and opening three more stores in 2019, three in 2020, five in 2021, and 13 in 2022.

"The number of people suffering from anxiety, depression, inflammation, pain, and other ailments continues to skyrocket. Our mission is to help people find natural alternatives to the many harmful pharmaceutical drugs on the market," said Alex Roshid Abdul, COO and Co-Owner of Mary Jane's CBD Dispensary. "We attribute our past, present, and future success to our offering the best customer experience combined with the highest quality products."

Featured CBD products include gummies, full and broad spectrum oil, isolate oil, hemp flower, lotions, pain cream, pre-rolled flower, and pet treats. Most importantly, all products are acquired from top white-labeling manufacturers in the US. Lab test results for each product are also posted on the company's website.

Heading into 2023, the focus is shifting from storefront retail growth to the company's wholesale/packaging division. Fueled by a heavy concentration on online marketing, more customers are now ordering directly from the website. Products are then shipped from the company's wholesale location in San Antonio.

Abdul is available for interviews to talk more about things like the growing demand for CBD products, Mary Jane's unique business model, and trends in the CBD industry as a whole.

For more information visit www.mjcbdd.com. Contact [email protected] or call (210) 689-1641 for media inquiries.

"The number of people suffering from anxiety, depression, inflammation, pain, and other ailments continues to skyrocket. Our mission is to help people find natural alternatives to the many harmful pharmaceutical drugs on the market," said Alex Roshid Abdul, COO and Co-Owner.

Media Contact

Alex Roshid Abdul, Mary Jane's CBD Dispensary Inc., 1 (210) 689-1641, [email protected], www.mjcbdd.com

 

SOURCE Mary Jane's CBD Dispensary Inc.


These press releases may also interest you

at 03:00
MD Logistics LLC (hereinafter "MD"), a group company of NIPPON EXPRESS HOLDINGS, INC., is remaking the North Area of its existing warehouse in Plainfield in the U.S. state of Indiana into a dedicated pharmaceutical facility that will commence...

at 03:00
Compliancy Group strives to educate on all things healthcare compliance. Understanding how breaches occur and how to prevent them is a key component of compliance. Each month, Compliancy Group releases a breach report to spread awareness. Hacking...

at 03:00
Clarivate Plc a leading global provider of transformative intelligence, today announced the full agenda for the 2nd annual Summit LATAM, which will be held in Milan on October 7, 2024, ahead of the CPHI Milan conference. In partnership with the...

at 02:23
The members of the Nomination Committee for the Annual General Meeting (AGM), that takes place on May 8, 2025, have been appointed and comprises of the following members: Henrik Kjaer Hansen, (Chairman, appointed by Novo Holdings A/S)Claus Berner...

at 02:20
Skanska has signed a contract with Harris Health System for the construction of a new healthcare building in Houston, Texas, USA. The contract is worth USD 54M, about SEK 570M, which will be included in the US order bookings for the third quarter of...

at 00:32
ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, today announced that it has entered into a clinical trial collaboration and supply agreement with MSD (a subsidiary of Merck & Co., Inc., Rahway, NJ, USA), to evaluate...



News published on and distributed by: